miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 26, 2026

GasBuddy flags worrisome gas price trend, sends message on what's next

View original at finance.yahoo.com
GasBuddy flags worrisome gas price trend, sends message on what's next The Israel-U.S. war with Iran is proving to be frustrating. Not just for the combatants or the politicians…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Crude oil shortages are growing in gasoline, jet fuel and related products due to insufficient supply

    60% confidence

  • Prices typically rise in the spring and early summer as U.S. refiners build supply and change their recipes to make gasoline more environmentally friendly

    60% confidence

  • He doesn't see any big price breaks soon. The will to talk just doesn't seem to be there.

    60% confidence

  • Trump did not know who was really in charge in Iran

    60% confidence

  • Gas prices in California, the highest-priced state, are nearing $6 on average and rising

    60% confidence

  • U.S. gas prices jumped from $2.972/gallon on Feb. 28 to $4.167/gallon on April 8, a gain of nearly 40% and an 83% jump for the year

    60% confidence

  • Travel time to Islamabad for the negotiation meeting was too great

    60% confidence

  • The cheapest gas in the United States is in Oklahoma, with a statewide average of $3.47

    60% confidence

Data points we hold from this source

United States Government · avg gas price per gallon4.07 USD
United States Government · avg gas price per gallon2.972 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
GasBuddy flags worrisome gas price trend, sends message on what's next — Source | Via News | es.VIA.NEWS